Our results indicate that higher sensitivity of combinations (TK1p + CA 125 or TK1p + HE4), along with 95% specificity, could offer the early detection of ovarian cancer and therefore improve the prognosis of patients. Here, WFDC2 is linked to ovarian carcinoma.